Large-scale testing (Phase 3)Study completedNCT02357576What this trial is testingStandard Lipid Therapy vs IVFE Minimization for Prevention of PNALDWho this might be right forCholestasis University of Michigan 22
Not applicableLooking for participantsNCT06274788What this trial is testingSafety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentWho this might be right forParenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more Fresenius Kabi 40
Not applicableApproved For MarketingNCT02929303What this trial is testingExpanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALDWho this might be right forTotal Parenteral Nutrition-induced Cholestasis Wake Forest University Health Sciences
Not applicableWithdrawnNCT01323907What this trial is testingCompassionate Use of Omegaven IV Fat EmulsionWho this might be right forTotal Parenteral Nutrition-induced Cholestasis Sivan Kinberg
Post-approval studies (Phase 4)Ended earlyNCT02476994What this trial is testingPediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid EmulsionWho this might be right forEssential Fatty Acid Deficiency (EFAD) Baxter Healthcare Corporation 1
Testing effectiveness (Phase 2)Study completedNCT01601652What this trial is testingCompassionate Use of an Intravenous Fish Oil Emulsion in Infants With CholestasisWho this might be right forParenteral Nutrition Associated Cholestasis Arthur J De Lorimier 12
Not applicableNo Longer AvailableNCT02121769What this trial is testingOmegaven Expanded Access ProtocolWho this might be right forParenteral Nutrition Associated Liver Disease St. Luke's Health System, Boise, Idaho
Not applicableStudy completedNCT01284049What this trial is testingEvaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver DiseaseWho this might be right forLiver Diseases Assistance Publique - Hôpitaux de Paris 31
Large-scale testing (Phase 3)Study completedNCT00910104What this trial is testingCholestasis Reversal: Efficacy of IV Fish OilWho this might be right forParenteral Nutrition Associated Liver DiseaseShort Bowel SyndromeGastrointestinal Disease Mark Puder 91
Not applicableApproved For MarketingNCT03072667What this trial is testingOmegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseWho this might be right forCholestasisLiver Diseases Catherine Cibulskis, MD
Large-scale testing (Phase 3)UnknownNCT01247012What this trial is testingMinimization of IntraLipid Versus OmegavenWho this might be right forCholestasisParenteral Nutrition Associated Liver Disease (PNALD) Children's & Women's Health Centre of British Columbia 40
Testing effectiveness (Phase 2)Study completedNCT00826020What this trial is testingEvaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced CholestasisWho this might be right forParenteral Nutrition Associated Liver Disease PNALDCholestasis University of Nebraska 72
Post-approval studies (Phase 4)Study completedNCT04555044What this trial is testingPediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)Who this might be right forEssential Fatty Acid Deficiency (EFAD) Baxter Healthcare Corporation 101